Cargando…

Editorial: Molecular biomarkers in hepatobiliary and pancreatic cancers: implications of non-coding RNAs and its therapeutic opportunities

Detalles Bibliográficos
Autores principales:	Roy, Souvick, Moloudizargari, Milad, Xu, Caiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411181/ https://www.ncbi.nlm.nih.gov/pubmed/37564042 http://dx.doi.org/10.3389/fmed.2023.1247320

Ejemplares similares

MicroRNAs in Hepatobiliary and Pancreatic Cancers
por: Saito, Yoshimasa, et al.
Publicado: (2011)

Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities
por: Cortesi, Michela, et al.
Publicado: (2023)

Editorial: Non-coding RNAs in heart failure
por: Booz, George W., et al.
Publicado: (2022)

Editorial: Innovative technologies and materials for treatments of hepatobiliary and pancreatic diseases
por: Li, Di, et al.
Publicado: (2023)

Hepatobiliary and pancreatic ascariasis
por: Khuroo, Mohammad S, et al.
Publicado: (2016)

Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs
por: Dirksen, K., et al.
Publicado: (2016)

Editorial: The role of genetics and non-coding RNAs in atrial fibrillation
por: Novelli, Valeria, et al.
Publicado: (2022)

Therapeutic Endoscopy of the Hepatobiliary and Pancreatic System: A Vietnamese Experience
por: Quocanh Anh, Le Quang
Publicado: (1997)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
por: Qian, Yuchen, et al.
Publicado: (2020)

Cholecystitis, Concealment of Hepatobiliary-Pancreatic Pathology: The Role of Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound
por: Zafar, Mansoor, et al.
Publicado: (2021)

Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011)

Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications
por: Li, Jiaying, et al.
Publicado: (2022)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Hartmann, Phillipp
Publicado: (2022)

Editorial: MicroRNAs—clinical biomarkers for atrial fibrillation
por: Moscoso, Isabel, et al.
Publicado: (2023)

Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2021)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Opportunities and Challenges of Digitization in Rheumatology
por: Sewerin, Philipp
Publicado: (2022)

Editorial: Extracellular vesicles in cancer immunosurveillance
por: Moloudizargari, Milad, et al.
Publicado: (2022)

Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021)

Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts
por: Urdaneta, Verónica, et al.
Publicado: (2017)

Pharmacological and therapeutic effects of Mentha Longifolia L. and its main constituent, menthol
por: Mikaili, Peyman, et al.
Publicado: (2013)

Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies
por: Sato, Keisaku, et al.
Publicado: (2020)

Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications
por: Elia, Leonardo, et al.
Publicado: (2017)

Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer
por: Zhang, Cangang, et al.
Publicado: (2021)

Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
por: Yu, Jianwen, et al.
Publicado: (2021)

Editorial: MicroRNAs in Heart Regeneration: Regulatory Mechanisms and Therapeutic Applications
por: Abdelwahid, Eltyeb, et al.
Publicado: (2022)

Therapeutic Uses and Pharmacological Properties of Garlic, Shallot, and Their Biologically Active Compounds
por: Mikaili, Peyman, et al.
Publicado: (2013)

EDITORIAL Implication of Non-coding RNAs in Cancer Biology and Cellular Physiology
por: Poltronieri, Dr. Palmiro
Publicado: (2015)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
por: Shrivastava, Apurva, et al.
Publicado: (2020)

Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments
por: Sun, Wanli, et al.
Publicado: (2022)

Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019
por: Singla, Vikas, et al.
Publicado: (2020)

Hepatobiliary and pancreatic surgery in the elderly: Current status
por: Papis, Davide, et al.
Publicado: (2020)

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
por: Patel, Kishan P., et al.
Publicado: (2020)

Role of artificial intelligence in hepatobiliary and pancreatic surgery
por: Bari, Hassaan, et al.
Publicado: (2021)

Hepatobiliary and pancreatic hemorrhage: Technical tools and tricks
por: Ball, Chad G.
Publicado: (2021)

Hepatobiliary and Pancreatic: An unusual cause of biliary obstruction
por: Saraiva, RO, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfn7bbb66jd08mosd9b7kp8jo9